Skip to main content

To: President Biden

Stop this outrageous Paxlovid increase, end Big Pharma greed!

Pfizer jacking up the price of Paxlovid is blatant profiteering off of an historically devastating public health crisis. A truly despicable display of corporate greed. We urge you to intervene and ensure that the COVID treatments remain accessible for ALL Americans.

Why is this important?

Paxlovid saves lives. And Pfizer is jacking up its price.

Pfizer just announced it’s going to nearly triple the price of the antiviral COVID drug that can help reduce symptoms, prevent hospitalizations, and save lives.1 Pfizer executives are prioritizing profits over patients. This is Big Pharma greed, plain and simple.

Pfizer’s CEO doesn’t need any more millions — he made $33 million in 2022,2 while so many Americans struggle to pay for the prescription drugs they need to survive. We must let President Biden know this is unacceptable.

Sign the petition: Tell President Biden to stop the corporate profiteering off of COVID treatments by guaranteeing access to all Americans.

Paxlovid costs $13 to make. Pfizer is going to sell it for $1,400.3 That’s a 10,000% price markup.

Drug corporations are making massive profits on medicine people need to survive. Pfizer became the first ever Pharma company to bring in $100 billion in revenue. That’s right, $100 billion.4 While everyday Americans are struggling to afford medications, Pfizer executives are getting richer and richer.

Big Pharma will always want to maximize profits. Big Pharma executives will always want fat bonuses. That's why President Biden must step in.

Add your name: Stop this outrageous Paxlovid increase, end Big Pharma greed!

Sources:

MSNBC, “The estimated production cost of Paxlovid: $13. Its new list price: $1400,” October 23, 2023.
Fierce Pharma, “Coming and going paid off for biopharma CEOs in 2022,” July 27, 2023.
MSNBC, “The estimated production cost of Paxlovid: $13. Its new list price: $1400,” October 23, 2023.
Fierce Pharma, “Coming and going paid off for biopharma CEOs in 2022,” July 27, 2023.

Categories

Partner

Updates

2023-11-17 19:36:12 -0500

20,000 signatures reached

2023-11-17 16:51:03 -0500

10,000 signatures reached

2023-11-17 16:17:59 -0500

5,000 signatures reached

2023-11-13 20:07:11 -0500

1,000 signatures reached

2023-11-08 20:01:18 -0500

500 signatures reached

2023-11-07 19:57:02 -0500

100 signatures reached

2023-11-07 18:17:49 -0500

50 signatures reached

2023-11-07 17:57:44 -0500

25 signatures reached

2023-11-07 17:49:29 -0500

10 signatures reached